BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, June 12, 2026
Home
»
Topics
»
Disease categories and therapies
» Substance use and poisoning
Substance use and poisoning
RSS
First patient dosed in phase III study of Zubsolv for new indication
June 19, 2013
Neumedicines receives BARDA award for HemaMax
June 11, 2013
Nippon Shinyaku launches Regtect in Japan
May 27, 2013
Neumedicines receives BARDA intent to exercise contract option on HemaMax
May 17, 2013
Biotie reports initiation of NIH-funded study of nepicastat in cocaine dependence
May 13, 2013
FDA issues complete response letter declining approval of Probuphine
May 3, 2013
Addex's GABA(B) receptor PAM reduces alcohol intake in preclinical model
April 30, 2013
Humanized anti-cocaine MAb demonstrates in vivo efficacy
April 30, 2013
Lundbeck launches Selincro in European markets
April 22, 2013
PharmAthene's rBChE shown to bind to broad spectrum of nerve agents
April 19, 2013
Previous
1
2
…
40
41
42
43
44
45
46
47
48
…
119
120
Next